If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Publishing research using ab12172? Please let us know so that we can cite the reference in this datasheet
ab12172 has been referenced in 3 publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
All lanes : Anti-HDAC4 antibody (ab12172) at 1/500 dilution
Lane 1 : Human Bladder cancer cell lysate treated with Betulinic acid, curcumin, Gefitinib for 48 hours.
Lane 2 : Human Bladder cancer cell lysate treated with Betulinic acid, curcumin, Gefitinib for 48 hours.
Lane 3 : Human Bladder cancer cell lysate treated with Betulinic acid, curcumin, Gefitinib for 48 hours.
Lane 4 : Human Bladder cancer cell lysate treated with Betulinic acid, curcumin, Gefitinib for 48 hours.
Lysates/proteins at 60 µg per lane.
Secondary
HRP-conjugated Goat anti-rabbit IgG. at 1/5000 dilution
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 140 kDa
Observed band size : 56 kDa (why is the actual band size different from the predicted?)
Exposure time : 15 minutes
Legend details amount of betulinic acid per lane.
This image is courtesy of an Anonymous Abreview.
All lanes : Anti-HDAC4 antibody (ab12172) at 1/500 dilution
Lane 1 : Lysate from wt control mouse heart tissue
Lane 2 : Lysate from Gq TG mouse heart tissue
Lysates/proteins at 20 µg per lane.
Secondary
HRP conjugated goat anti-rabbit IgG polyclonal at 1/5000 dilution
developed using the ECL technique
Predicted band size : 140 kDa
Observed band size : 140 kDa
Exposure time : 2 minutes
Image courtesy of an anonymous Abreview.
1
Call 01223 696 000 or contact us